Aspocid 75 mg 30 chewable tablets
CID Pharmaceuticals
CID Pharmaceuticals
Composition
Acetylsalicylic acid - 75 mg.
Excipients: mannitol, dextrose (glucose).
Product Description
Salicylate non-steroidal anti-inflammatory drug (NSAID) with a blood-thinning effect, preventing platelets from sticking together.
Indications for use
Secondary prevention of myocardial infarction.
Prevention of cardiovascular morbidity in patients with stable angina.
Unstable angina (except for the acute phase).
Prevention after coronary artery bypass graft and coronary angioplasty (except for the acute phase).
Secondary prevention of transient ischemic attacks and ischemic cerebrovascular events in the absence of intracerebral hemorrhage.
The drug is not intended for emergency situations and is limited to chronic diseases.
Method of administration and dosage
For oral administration: the tablet should be thoroughly chewed and washed down with a sufficient amount of liquid.
For adults, the recommended doses are: for secondary prevention of myocardial infarction — 75–160 mg once a day;
For stable angina — 75–160 mg once a day;
For unstable angina (outside the acute phase) — 75–100 mg once a day;
After coronary artery bypass graft — 75–160 mg once a day;
During coronary angioplasty (outside the acute phase) — 75–160 mg once a day;
For secondary prevention of transient ischemic attacks and ischemic cerebrovascular events (without intracerebral hemorrhage) — 75–325 mg once a day.
Treatment is subject to regular review by the attending physician. Contraindications: Children under 12 years of age, and the packaging also indicates a restriction up to 16 years of age without a special medical prescription.
Hypersensitivity to salicylates, aspirin, and other NSAIDs.
Tendency to bleeding.
Peptic ulcer of the stomach and duodenum.
Severe diseases of the heart, liver, and kidneys.
Pregnancy and lactation period.
Precautions
Use during the last trimester of pregnancy may prolong labor and increase premature bleeding.
Caution and strict medical supervision are required when prescribing to patients with cardiovascular system diseases and gastrointestinal tract diseases (especially elderly people).
Alcohol consumption is prohibited during treatment. Side effects: Headache.
Dizziness.
Confusion.
Hearing impairment.
Tinnitus.
Gastrointestinal disorders (nausea, heartburn, vomiting, abdominal pain, diarrhea).
Gastric microbleedings.
Renal dysfunction and acute renal failure.
Pregnancy and lactation
Contraindicated during pregnancy and breastfeeding.
Use in the last trimester requires special caution due to the risk of bleeding and impact on labor activity.
Storage conditions
Store at a temperature not exceeding 30°C in a place inaccessible to children.
Packaging
Cardboard box contains 30 chewable tablets.